Indications
Rytary capsules are used to treat Parkinson's disease, as well as parkinsonism that develops after encephalitis or from exposure to carbon monoxide or manganese.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Levodopa: Levodopa is the metabolic precursor of dopamine. It crosses the blood-brain barrier and is presumably converted to dopamine in the brain. This is thought to be the mechanism by which levodopa relieves the symptoms of Parkinson's disease.
Carbidopa: When levodopa is given by mouth, it is rapidly decarboxylated to dopamine in tissues outside the brain, so only a small portion of a given dose reaches the central nervous system unchanged. Carbidopa inhibits this peripheral decarboxylation of levodopa, making more levodopa available for delivery to the brain.
Pregnancy & Breastfeeding
Pregnancy: No adequate data exist on the developmental risks of RYTARY use in pregnant women. Animal studies have shown carbidopa-levodopa to be developmentally toxic, including teratogenic effects, at doses relevant to clinical use.
Breastfeeding (Lactation): Levodopa has been detected in human milk following carbidopa-levodopa use. There is no data on whether carbidopa passes into human milk, on how levodopa or carbidopa might affect a breastfed infant, or on their effects on milk production. Because levodopa lowers prolactin secretion in humans, breastfeeding mothers may experience reduced milk supply. Carbidopa is excreted in the milk of rats.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.